We have a unique CRO profile providing unique and innovative dual expertise combining clinical research implementation with the development of customized IT applications specific to the pharmaceutical industry.
2017 WUHAN Convention on Innovative therapeutics for Cancer and Ageing diseases
Mrs Sylvie Kahn (VP Operations) and Mrs Virginie Droal (Clinical Project Manager) from PopsiCube-Fovea give a talk at the 2017 WUHAN Convention on Innovative therapeutics for Cancer and Ageing diseases conference in Wuhan (China) on October 24-27, 2017 @ Huazhong University of Science and Technology.
Meet POPSICUBE-FOVEA @ AFCROs 2018
The 7th Day of Clinical Research organized by AFCROs will be held on Tuesday, January 30, 2018 @ Meridien Etoile, Paris, France.
Meet POPSICUBE-FOVEA team at booth 21.
PopsiCube-FOVEA @ DIA 2017 Chicago
PopsiCube-Fovea will be present at the 2017 Annual DIA Convention in Chicago, IL from Monday June 19, 2017 to Wednesday June 21, 2017 at exhibit #2618.
E2MAO study publication
Pressure ulcers prevention efficacy of an alternating pressure air mattress in elderly patients: E²MAO a randomised study P. Sauvage, M. Touflet, C. Pradere, F. Portalier, J-M. Michel, P. Charru, Y. Passadori, R. Fevrier, A-M. Hallet-Lezy, F. Beauchêne, and B. Scherrer Journal of Wound Care 2017 26:6, 304-312 Objective: Our aim was to compare Axtair One, […]
PopsiCube acquires FOVEA Group CRO
PARIS, France – June 1st, 2017 – POPSICUBE sarl, offering efficient and innovative clinical, and consulting services to the healthcare industry, today announced it has completed the acquisition of FOVEA SAS, a recognized French leader of drug development services to the pharmaceutical, biotechnology, and medical device industries. Financial terms of the transaction were not disclosed. […]
